That is great news.

The article mentions the use of a diagnostic test developed by Creatv MicroTech.

Is that new or relevant? (New to me but might have been missing it.)

CytoDyn Results on 12-Month Analysis of Metastatic Triple-Negative Breast Cancer Patients
These results were determined by the LifeTracDx test developed by Creatv MicroTech, Inc., which test appears to aid as a parallel diagnostic tool in identifying patients that respond to leronlimab.

TIA

__________________

Posted By: Figgs
Nice article, great news:
https://trialsitenews.com/cytodyn-reports-12-...-survival/